http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592116-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
filingDate 2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f3dd17594ad64e4cb3520d64658dc47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab9071bcd7f6dd9938628fac258a1cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd2bc361eb0556e8c53ffef2ec9e903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e506728080d96b12a9353fc88b85f414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ecade645301d0536191d8372b3d68dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae6bcb6dd3f18a1c58fd6676c65fcf9
publicationDate 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104592116-A
titleOfInvention 1,3,5-trisubstituted pyrazole compounds and their preparation methods and applications
abstract The invention discloses 1,3,5-trisubstituted pyrazole compounds and their preparation method and application, the structure of which is shown in general formula (I): Wherein, R is hydrogen, halogen, methyl or trifluoromethyl; R is methyl, ethyl, n - propyl, isopropyl, cyclopropyl or an aliphatic hydrocarbon chain or ring with 4-8 carbons; R 3 , R 4 , R 5 , R 6 or R 7 are hydrogen, halogen, methyl, trifluoromethyl, methoxy, trifluoromethoxy, ethynyl, nitro or nitrile; X is carbonyl, Amide groups, urea, thiourea. The 1,3,5-trisubstituted pyrazole compounds of the present invention, especially 8aM06, 8aM21, 8aM23, 8aM25, 8aM26, 8aE02, 8aE08, 8aE10, 8eE01 and 8cE01 have strong effects on prostate cancer cells LNCaP and PC-3 The cell growth inhibitory activity can be used to prepare antitumor drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106916107-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106916107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109422690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109516956-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109516956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844514-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685371-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107400088-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844514-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107400088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112694472-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107903213-A
priorityDate 2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103848810-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009065096-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467028955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466419569

Total number of triples: 35.